Together, we can end viral hepatitis.
We are the only grant-making organization dedicated exclusively to the mission of ending viral hepatitis. See our (updated) Call for Proposals.
By funding a variety of the most effective activities, EndHep2030 intends to overcome the barriers that prevent countries from properly addressing viral hepatitis — a pandemic that will kill 1.4 million people this year — as a global public health threat.
Our catalytic funding will speed the elimination of viral hepatitis by supporting the development of sustainable strategic plans at the national and sub-national level to guide effective program implementation; by showing how countries can optimize their human and financial resources within health budgets; by increasing the availability of country-specific data that inform where and how to intervene most efficiently and effectively; and, by building health system capacity to deliver quality hepatitis prevention and treatment services.
EndHep2030’s catalytic funding will be the spark that sets this historic effort in motion. MORE